Literature DB >> 17410004

Genetic heterogeneity in patients with multiple neoplastic lung lesions: a report of three cases.

Mariëlle I Gallegos Ruiz1, Hester van Cruijsen, Egbert F Smit, Katrien Grünberg, Gerrit A Meijer, José A Rodriguez, Bauke Ylstra, Giuseppe Giaccone.   

Abstract

INTRODUCTION: It is important to determine the relation among the various lesions in patients presenting with multiple malignant lung tumors to define the best treatment approach. A better understanding of the molecular alterations present in the different lesions may help in defining this relation.
METHODS: We performed a detailed molecular analysis of several tumor specimens obtained from three patients presenting with multiple lung lesions. Tumor specimens were analyzed for epidermal growth factor receptor (EGFR) and k-ras mutations by direct DNA sequencing. In addition, a genome-wide chromosomal copy number analysis was performed on DNA extracted from the various lesions using array-based comparative genomic hybridization.
RESULTS: In one case, a deletion of 15 base pairs in exon 19 of EGFR was present in all tumor sites analyzed. Furthermore, a similar pattern of chromosomal aberrations was observed among the various lesions, suggesting that they share the same clonal origin. In the other two cases, in contrast, we identified distinct k-ras genotypes among the various lesions from the same patient. These lesions, moreover, showed different chromosomal aberration patterns, indicating that they may have different underlying pathways of tumorigenesis.
CONCLUSION: Our results show that EGFR and k-ras mutation analysis, combined with chromosomal copy number profiling, can help in defining the relationship among different tumors in one patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17410004

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  7 in total

1.  Testing clonal relatedness of tumors using array comparative genomic hybridization: a statistical challenge.

Authors:  Irina Ostrovnaya; Colin B Begg
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

2.  A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data.

Authors:  Irina Ostrovnaya; Adam B Olshen; Venkatraman E Seshan; Irene Orlow; Donna G Albertson; Colin B Begg
Journal:  Stat Med       Date:  2010-07-10       Impact factor: 2.373

3.  Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers.

Authors:  Nicolas Girard; Irina Ostrovnaya; Christopher Lau; Bernard Park; Marc Ladanyi; David Finley; Charuhas Deshpande; Valerie Rusch; Irene Orlow; William D Travis; William Pao; Colin B Begg
Journal:  Clin Cancer Res       Date:  2009-08-11       Impact factor: 12.531

Review 4.  [Comparison of EGFR and KRAS status between primary non-small cell lung cancer and corresponding metastases: a systematic review and meta-analysis].

Authors:  Chengbo Han; Huawei Zou; Jietao Ma; Yang Zhou; Jianzhu Zhao
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-09

5.  Clonality analysis of pulmonary tumors by genome-wide copy number profiling.

Authors:  Julien P L Vincenten; Hendrik F van Essen; Birgit I Lissenberg-Witte; Nicole W J Bulkmans; Oscar Krijgsman; Daoud Sie; Paul P Eijk; Egbert F Smit; Bauke Ylstra; Erik Thunnissen
Journal:  PLoS One       Date:  2019-10-16       Impact factor: 3.240

6.  Discordance of Epidermal Growth Factor Receptor Mutation between Brain Metastasis and Primary Non-Small Cell Lung Cancer.

Authors:  Kyung Min Kim; Seung Hoon Lee; Seung Min Kim; Nae Yu Kim; Ho Shin Gwak; Sang Hoon Shin; Ji Woong Kwon; Heon Yoo
Journal:  Brain Tumor Res Treat       Date:  2019-10

7.  Mutational landscape of multiple primary lung cancers and its correlation with non-intrinsic risk factors.

Authors:  Yasuhiro Koh; Tomoya Kawaguchi; Motohiro Izumi; Jun Oyanagi; Kenji Sawa; Mitsuru Fukui; Koichi Ogawa; Yoshiya Matsumoto; Yoko Tani; Tomohiro Suzumura; Tetsuya Watanabe; Hiroyasu Kaneda; Shigeki Mitsuoka; Kazuhisa Asai; Masahiko Ohsawa; Nobuyuki Yamamoto
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.